市場調査レポート
商品コード
1441198
タンジェンシャルフロー濾過の世界市場規模、シェア、成長分析、製品別、技術別、用途別、最終用途別-産業予測、2023~2030年Global Tangential Flow Filtration Market Size, Share, Growth Analysis, By Product, By Technology, By Application, By End-use - Industry Forecast 2023-2030 |
タンジェンシャルフロー濾過の世界市場規模、シェア、成長分析、製品別、技術別、用途別、最終用途別-産業予測、2023~2030年 |
出版日: 2024年02月22日
発行: SkyQuest
ページ情報: 英文 157 Pages
納期: 3~5営業日
|
タンジェンシャルフロー濾過の世界市場規模は2022年に21億米ドルと評価され、予測期間(2024~2031年)のCAGRは11.53%で、2023年の23億4,000万米ドルから2031年には56億米ドルに成長する展望です。
タンジェンシャルフロー濾過(TFF)技術は、糖尿病、がん、関節リウマチなど様々な疾患に対処するためのバイオ医薬品に対するニーズの高まりにより、需要が急増しています。こうした需要の高まりが市場成長の主要要因となっています。TFFには、高性能、再現性、各社によるTFF新製品の採用など、いくつかの利点があり、これらすべてが市場拡大に寄与しています。さらに、業界投資の増加や政府の積極的な取り組みにより、バイオ医薬品製造における施設の拡大や新しいツールや技術の研究開発が活発に行われています。COVID-19ワクチンの大量生産もまた、大手企業に新たな機会をもたらしています。さらに、特にCOVID-19ワクチン生産においてシングルユースの生物学的処理装置が受け入れられつつあるため、エンドユーザーによるシングルユースTFF装置の採用が増加しています。例えば、Pall Corporationは、ワクチン製造に必要なシングルユース技術に対する需要の高まりに対応するため、1億1,400万米ドルを投資しました。さらに、流量の増加、製品蓄積の減少、洗浄の簡素化、フィルター交換の簡素化など、従来のフロー濾過に対するTFFの付加的な利点が、その高い利用率と市場成長の一因となっています。TFFの連続濾過プロセスは、自動化と相まって処理時間を短縮し、システムの回復力と生産性を高める。こうした利点により、TFFシステムはバイオ医薬品製造に欠かせないものとなっています。さらに、各社は市場での存在感を高め、革新的な技術を開発しています。例えば、Repligen Corporationは2021年にTFDF(Tangential Flow Depth Filtering)フィルターの特許を取得し、ホールドアップ量を最小限に抑え、高フラックスで1回使用のソリューションを提供しています。このような進歩や技術革新は、予測期間中の業界拡大を促進すると予想されます。
Global Tangential Flow Filtration Market size was valued at USD 2.10 Billion in 2022 and is poised to grow from USD 2.34 Billion in 2023 to USD 5.60 Billion by 2031, at a CAGR of 11.53% during the forecast period (2024-2031).
Tangential flow filtration (TFF) technology is experiencing a surge in demand due to the growing need for biopharmaceuticals to address various diseases, including diabetes, cancer, and rheumatoid arthritis. This rising demand is the primary driver of market growth. TFF offers several advantages such as high performance, reproducibility, and the introduction of new TFF products by companies, all contributing to the market's expansion. Moreover, increased industry investments and supportive government initiatives have led to facility expansions and active research and development efforts for new tools and technologies in biopharmaceutical production. The mass production of the COVID-19 vaccine has also created new opportunities for major firms. Additionally, the adoption of single-use TFF equipment by end-users has increased due to the growing acceptance of single-use biological processing equipment, especially in COVID-19 vaccine production. For example, Pall Corporation invested USD 114 million to meet the rising demand for single-use technology required in vaccine production. Furthermore, the added benefits of TFF over traditional flow filtration, such as increased flow rate, reduced product build-up, simplified cleaning, and filter replacement, contribute to its high utilization rate and market growth. The continuous filtering process of TFF, coupled with automation, reduces processing time and enhances system resilience and productivity. These advantages have made TFF systems indispensable in biopharmaceutical production. Additionally, companies are enhancing their market presence and developing innovative technologies. For instance, Repligen Corporation introduced a patent in 2021 for their Tangential Flow Depth Filtering (TFDF) filter, offering a one-use solution with minimal hold-up volume and high flux. Such advancements and innovations are expected to drive industry expansion over the forecast period.
Top-down and bottom-up approaches were used to estimate and validate the size of the Global Tangential Flow Filtration and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analysed to get the final quantitative and qualitative data.
Global Tangential Flow Filtration Market Segmental Analysis
The global tangential flow filtration market is segmented on the basis of product, technology, application, end-use, and region. Based on product, the market is segmented into Single-use Tangential Flow Filtration Systems, Reusable Tangential Flow Filtration Systems, Membrane Filters, and Filtration Accessories. In terms of technology, the market is segmented into Ultrafiltration, Microfiltration, Nanofiltration, and Others. Based on Application the market is segmented into Protein Purification, Vaccine and Viral Vectors, Antibody Purification, Raw Material Filtration, Others. Based on End-user the market is segmented into Pharmaceutical & Biotechnology Companies, Contract Research Organizations & Contract Manufacturing Organizations, Academic Institutes & Research Laboratories. Based on region the global Tangential Flow Filtration Market is segmented into North America, Europe, Asia-Pacific, South America, and MEA.
Drivers of the Global Tangential Flow Filtration Market
The increasing need for biopharmaceuticals like monoclonal antibodies, vaccines, and recombinant proteins serves as a key catalyst for the TFF market. TFF finds extensive application in the biopharmaceutical sector for purifying and concentrating these products.
Restraints in the Global Tangential Flow Filtration Market
Introducing TFF systems can entail considerable initial expenses for equipment, consumables, and infrastructure. Moreover, ongoing operational costs related to maintenance, validation, and cleaning can be substantial. These factors might limit the uptake of TFF, especially among small and medium-sized enterprises operating within constrained budgets.
Market Trends of the Global Tangential Flow Filtration Market
The adoption of single-use TFF systems is on the rise in the market. Single-use TFF provides numerous benefits such as decreased risk of cross-contamination, streamlined cleaning and validation procedures, and enhanced operational adaptability. The convenience and cost-efficiency of single-use systems are fuelling their incorporation across diverse biopharmaceutical manufacturing operations.
The demand for TFF systems with greater capacity and throughput is escalating alongside the rising production volumes of biopharmaceuticals. Market participants are concentrating on creating high-capacity TFF systems capable of managing larger quantities of feedstock, thereby enhancing process efficiency. These systems facilitate increased productivity and scalability, meeting the industry's requirements for large-scale bioprocessing.
Rise of Comprehensive TFF Solutions: Integrated TFF platforms, which amalgamate various functions like TFF, viral clearance, and ultrafiltration, are increasingly becoming popular in the industry. These unified platforms provide streamlined operations, minimized space requirements, and enhanced process oversight. They facilitate smoother and more effective processes, lessening the reliance on separate systems and elevating manufacturing efficiency as a whole.
Embracing Enhanced TFF Membranes and Materials: Industry participants are consistently dedicating resources to research and innovation to advance TFF membrane technologies and create novel materials. The emphasis lies in refining membranes to boost selectivity, flux rates, and resistance to fouling, aiming to optimize TFF procedures. Additionally, exploration of innovative materials and coatings is underway to tackle distinct filtration hurdles and enhance overall operational efficacy.